A*STAR IMCB Welcomes Professor Rickie Patani and Dr Xia Yun
Read More
Congratulations to Dr Tee Wee Wei on His Promotion to Associate Professor with Tenure
Zeroing in on the Root of Gastric Cancer
Unbinding the “Undruggable”: How Molecular Glues Could Change the Way We Treat Disease
Study identifies novel pan-TEAD inhibitors to overcome drug resistance in cancer
Study reveals early abnormalities in liver cells derived from clinically healthy SMA carriers
SINGAPORE SCIENTISTS DISCOVER LUNG CANCER'S "BODYGUARD SYSTEM" – AND HOW TO DISARM IT
SINGAPORE SCIENTISTS SHOW TARGETING CANCER STEM CELLS CAN PREVENT GASTRIC CANCER RECURRENCE
A*STAR IMCB Researcher Honoured with the L’Oréal–UNESCO For Women in Science Award
SINGAPORE SCIENTISTS IDENTIFY MARKERS OF KEY STEM CELL POPULATIONS DRIVING COLORECTAL CANCER FORMATION
Celebrating Postdocs at A*STAR IMCB’s Inaugural Symposium
New Colon Cancer Models Pinpoint Stem Cells as Cancer Origins
SINGAPORE RESEARCHERS DEVELOP AI TOOL TO PREDICT LIVER CANCER RECURRENCE
Singapore-Developed Cancer Drug Shows Promise as Treatment for Blindness
A*STAR IMCB Scientists Develop Proteomics Pipeline to Strengthen Safety of Alternative Proteins
Phase II Trial Completed – Singapore’s New Anti-Cancer Drug One Step Away from Market
Unlocking Pluripotency: What Powers a Stem Cell’s Identity?
SINGAPORE-DEVELOPED CANCER IMMUNOTHERAPY OFFERS NEW HOPE FOR LATE-STAGE CANCER PATIENTS
A*STAR IMCB Researchers Awarded NRF CRP Funding to Advance Research in Neurodegeneration and Drug Resistance
Local Scientific Research Uncovers Why Melanoma Is Hard to Treat, Plans to Partner with Pharmaceutical Firms to Fight Cancer
